The study suggests a cellular redox pathway (selenium vs thiol axis) that is altered differently in Crohn's disease versus colorectal cancer, which could point to disease vulnerabilities and possible links to treatment...

The study suggests that in IBD the gut microbiome’s functional impact on immune signalling is shifted toward inflammation even when composition appears similar to controls.

Perianal inflammatory lesions are common in Crohn's disease and may mark higher cancer-related risk; knowing their association with worse survival after anorectal cancer surgery can inform discussions about prognosis and...

A simple blood ratio measured before surgery (LCR) may help predict which children with UC are at higher risk of surgical site infection after IPAA, potentially guiding preoperative care.

Findings are relevant because they describe outcomes and predictors of conversion for a minimally invasive surgery option (SILS) that some patients with Crohn's disease may be offered. Understanding risk factors can help...

For patients hospitalized with steroid-refractory ASUC, an effective oral rescue option could be useful when standard biologics are unavailable or contraindicated. The study also highlights that high colonic CMV DNA may...

Elevated pancreatic enzymes are relatively common in IBD and can reflect very different conditions (benign asymptomatic elevations, pancreatitis variants, or autoimmune pancreatitis). Recognizing phenotype-specific...

Based on the title and source metadata, this appears to be a clinical study related to Crohn's disease, Inflammatory bowel disease, and Tests and monitoring. The original article is from Journal of Crohn's & colitis.

The study links a traditional herbal formula to improved colitis in mice and to changes in bile-acid metabolism through the FXR–FGF15 pathway, suggesting a mechanistic route that could inform future preclinical or...

Researchers are investigating RBM47 because it influences RNA processing and immune pathways that could modify inflammation and disease processes relevant to IBD. If borne out, RBM47 could become a biomarker or...

B cells and antibodies appear to play active, regulatory roles in gut inflammation and tissue organization in IBD. Understanding this axis could inform new therapies or biomarkers that change how inflammation is detected...

If you have IBD and joint symptoms, this study suggests your joint complaints may reflect measurable immune changes that partly overlap with spondyloarthritis, not just non-specific pain. That could mean joint symptoms...

This paper describes a new engineered, off-the-shelf regulatory T cell therapy (TRX103) designed to restore immune tolerance and that is already entering early clinical trials for treatment-refractory Crohn’s disease.

Fatigue is a common, disabling symptom in people with IBD with unclear causes. Finding reproducible immune or infectious signatures related to fatigue could point toward new research directions and, eventually, markers...

Researchers identified a defined pectin from Sanguisorba officinalis that reduced inflammatory cytokine release in cells and improved outcomes in a mouse colitis model, suggesting a new lead for IBD drug discovery.

Mitochondrial dysfunction may contribute to IBD symptoms and disease progression; therapies that protect or restore mitochondrial function could become future treatment strategies. People interested in complementary or...

Sarcopenia is common in Crohn's disease and is linked to worse outcomes; a simple GNRI-based prediction tool could help identify at-risk patients without routine CT scanning.

Finding monogenic causes in infants with congenital diarrheas or VEOIBD can directly affect diagnosis, genetic counseling, and management. Populations with higher consanguinity may have higher diagnostic yields for...

Infliximab dosing can be hard to personalize. This study shows that selecting pharmacokinetic models based on IBD type and severity can improve how well drug levels are predicted, which could help tailor dosing for...

Identifying genetic predictors of thiopurine-induced leukopenia could help prevent a serious drug side effect by improving pre-treatment genetic screening and dose decisions for people with IBD.

Blood-based inflammatory ratios like CRP/albumin were associated with higher odds of needing anti‑TNF therapy, colectomy, and longer hospital stays in moderate–severe UC, suggesting potential utility as complementary...

Perianal fistulas are a serious complication of Crohn’s disease with limited high-quality trial evidence. This randomized trial suggests ustekinumab may increase the chance of combined clinical and MRI remission at 12...

A high-profile athlete describing recovery from ulcerative colitis and Crohn’s disease highlights that people with IBD can regain strength and return to demanding activities—something patients and families may find...

Anorectal stricture is a disabling Crohn’s complication that often requires surgery; a validated QoL threshold could help identify who should be prioritised for surgical review. This may make shared decision-making and...

This trial is testing whether a rectally delivered probiotic can change the gut microbiome and promote mucosal healing in people with mild-to-moderate ulcerative colitis (and includes some Crohn's patients). If...

This trial is testing guselkumab (an IL‑23 inhibitor) in a real‑world UC cohort and will measure endoscopic and histologic remission at 48 weeks — outcomes that matter to people managing moderate‑to‑severe ulcerative...

This trial is testing a new investigational antibody (XmAb942) specifically in people with moderately to severely active ulcerative colitis who have not responded to prior therapies. Early‑phase studies determine safety,...

This trial is testing whether adding vedolizumab after autologous stem cell transplant can improve remission rates for people with severe Crohn's disease that has failed multiple therapies.

This FDA label update affects people with IBD because tofacitinib is an approved JAK inhibitor for moderately to severely active ulcerative colitis and carries serious safety warnings that may influence treatment choices...

This report shows intestinal tuberculosis can present like inflammatory bowel disease with lower GI bleeding, leading to diagnostic delay; correct identification allowed targeted anti-TB and HIV therapy and clinical...

Cure8 found this source from Journal of physiological investigation, but the page could not be read reliably yet. It is tagged for Ulcerative colitis, Inflammatory bowel disease, and Research and clinical trials. Open...

This meta-analysis suggests people with IBD face higher risks of major cardiovascular events (heart attack, ischemic heart disease, ischemic stroke), which may matter for monitoring and preventive care. Higher risk...

Researchers report links between copper-driven cell death pathways and IBD biology; identifying cuproptosis-related biomarkers or drugs could open new diagnostic or therapeutic avenues for people with Crohn's disease or...

Noninvasive ultrasound could make assessment and monitoring of ulcerative colitis quicker and more accessible, including bedside evaluation and better rectal/pouch assessment with TPUS—potentially reducing reliance on...

This review summarizes many observational studies to identify dietary and environmental factors that may influence the risk of developing ulcerative colitis, which could help guide future research and prevention efforts...

The review suggests matrine and oxymatrine reduce inflammation and oxidative stress in animal UC models, pointing to potential new therapeutic approaches. People with UC may want to know about directions in preclinical...

Diet is a modifiable factor many people with IBD try to use to feel better. This review summarizes current evidence that a Mediterranean-style eating pattern may help quality of life and is linked to lower inflammation...

Noninvasive tools that reliably detect postoperative recurrence could reduce the need for frequent invasive endoscopy and help target earlier intervention for people with Crohn's disease after surgery.

This study looks at how statistically "fragile" results are in trials of new IBD treatments. Patients and clinicians should know that trial size, treatment type, and whether the result was a primary outcome affect how...

Based on the title and source metadata, this appears to be a case report related to Ulcerative colitis, Colorectal cancer, and Procedures and surgery. The original article is from Gastroenterology report.

Fournier’s gangrene is a life-threatening infection that can occur in people with active intestinal inflammation or after perineal trauma; the case shows how rapidly it can progress and how many surgeries may be needed,...

This label update affects people with Crohn’s disease or ulcerative colitis because it spells out approved uses, age ranges, and the official dosing schedules and safety warnings for ustekinumab (STELARA). Changes in the...

Based on the title and source metadata, this appears to be a patient education related to Inflammatory bowel disease and Medications. The original article is from hmpgloballearningnetwork.com.

Parasitic infection can closely mimic Crohn’s disease with ileitis and partial small-bowel obstruction; recognizing exposure history and eosinophilia may prevent misdiagnosis and lead to curative treatment.

A pooled analysis found modest differences in cardiac structure and function in people with IBD versus controls, which may relate to the higher cardiovascular risk seen in this population.

The study suggests nickel accumulation and iron deficiency may be linked with more severe IBD. If confirmed, blood metal and micronutrient levels could help researchers understand disease mechanisms and guide nutritional...

If you or your clinician are considering dietary therapy like the CDED for Crohn's disease, microbiome features at baseline may influence who achieves sustained remission. Understanding these links could help personalize...

m6A RNA methylation regulators are emerging as potential targets that may influence immune-driven inflammation in diseases that matter to people with IBD. Understanding these pathways could point toward new precision...